Steroid/NN
dose/NN
sparing/NN
:/:
pharmacodynamic/JJ
responses/NNS
to/TO
single/JJ
versus/CC
divided/JJ
doses/NNS
of/IN
methylprednisolone/NN
in/IN
man/NN
./.

Inhibitory/JJ
drug/NN
interactions/NNS
affecting/VBG
the/DT
metabolism/NN
of/IN
methylprednisolone/NN
(/(
MP/NN
)/)
may/MD
produce/VB
either/CC
steroid/NN
sparing/NN
or/CC
adverse/JJ
effects/NNS
partly/RB
by/IN
increasing/VBG
the/DT
exposure/NN
time/NN
to/TO
the/DT
steroid/NN
./.
=====
This/DT
phenomenon/NN
can/MD
be/VB
mimicked/VBN
by/IN
administering/VBG
MP/NN
in/IN
divided/JJ
doses/NNS
./.
=====
Two/CD
types/NNS
of/IN
responses/NNS
were/VBD
compared/VBN
after/IN
a/DT
single/JJ
MP/NN
dose/NN
(/(
40/CD
mg/NN
bolus/NN
)/)
and/CC
a/DT
divided/JJ
regimen/NN
(/(
20/CD
mg/NN
bolus/NN
and/CC
a/DT
5/CD
mg/NN
bolus/NN
8/CD
hours/NNS
later/RB
)/)
in/IN
six/CD
healthy/JJ
male/JJ
volunteers/NNS
./.
=====
The/DT
suppression/NN
of/IN
basophils/NNS
measured/VBN
as/IN
whole/JJ
blood/NN
histamine/NN
and/CC
plasma/NN
cortisol/NN
concentrations/NNS
was/VBD
assessed/VBN
during/IN
32/CD
hours/NNS
./.
=====
The/DT
37.5/CD
%/NN
reduction/NN
in/IN
dose/NN
produced/VBD
a/DT
23/CD
%/NN
overall/RB
decreased/VBN
blood/NN
histamine/NN
response/NN
./.
=====
A/DT
pharmacodynamic/JJ
model/NN
for/IN
basophil/NN
cell/NN
distribution/NN
to/TO
and/CC
from/IN
an/DT
extravascular/JJ
compartment/NN
describes/VBZ
the/DT
effects/NNS
of/IN
MP/NN
after/IN
both/DT
regimens/NNS
./.
=====
A/DT
slower/JJR
initial/JJ
decline/NN
in/IN
blood/NN
histamine/NN
after/IN
the/DT
divided/JJ
regimen/NNS
may/MD
be/VB
related/JJ
to/TO
incomplete/JJ
suppression/NN
of/IN
basophil/NN
cell/NN
return/NN
to/TO
blood/NN
./.
=====
The/DT
50/CD
%/NN
inhibitory/JJ
concentrations/NNS
of/IN
MP/NN
of/IN
about/RB
5/CD
ng/ml/NN
were/VBD
similar/JJ
for/IN
both/DT
regimens/NNS
./.
=====
The/DT
decline/NN
and/CC
return/NN
of/IN
cortisol/NN
concentrations/NNS
were/VBD
similar/JJ
between/IN
MP/NN
treatments/NNS
with/IN
suppression/NN
continuing/VBG
for/IN
24/CD
hours/NNS
./.
=====
The/DT
50/CD
%/NN
inhibitory/JJ
concentrations/NNS
of/IN
MP/NN
values/NNS
for/IN
adrenal/JJ
suppression/NN
were/VBD
about/RB
1/CD
ng/ml/NN
./.
=====
Pharmacodynamic/JJ
modeling/NN
is/VBZ
useful/JJ
in/IN
quantitating/VBG
corticosteroid/NN
responses/NNS
and/CC
generally/RB
predicted/VBD
the/DT
"/``
dose-sparing/JJ
"/''
effects/NNS
that/WDT
were/VBD
achieved/VBN
by/IN
prolonging/VBG
MP/NN
plasma/NN
concentrations/NNS
./.
=====
This/DT
study/NN
supports/VBZ
previous/JJ
clinical/JJ
observations/NNS
that/IN
patients/NNS
may/MD
require/VB
morning/NN
through/IN
evening/NN
exposure/NN
to/TO
MP/NN
to/TO
optimize/VB
efficacy/NN
while/IN
adrenal/JJ
suppression/NN
is/VBZ
being/VBG
minimized/VBN
./.